Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Quinolinone farnesyl transferase inhibitors for the treatment of synucleinopathies and other indications

Quinolinone farnesyl transferase inhibitors for the treatment of synucleinopathies and other indications

US Patent 8232402 · Granted Jul 31, 2012

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Fluorinated integrin antagonists2025
Systems, methods and devices for peripheral neuromodulation2025
Systems and methods for mechanogenetic functional ultrasound imaging2024
Systems, methods and devices for peripheral neuromodulation2024
Substituted pyrazolo[1,5-a]pyrimidines as glucocerebrosidase activators2024
Substituted pyrazolo[1,5-a]pyrimidines and their use in the treatment of medical2024
Systems, methods and devices for peripheral neuromodulation of the leg2024
Substituted imidazo[1,2-b]pyridazines, substituted imidazo[1,5-b]pyridazines, re2024
Fluorinated integrin antagonists2023
Imidazo[1,5-a]pyrimidinyl carboxamide compounds and their use in the treatment o2022
Substituted imidazo[1,5-a]pyrimidines and their use in the treatment of medical 2022
Substituted pyrrolo[1,2-a]pyrimidines and their use in the treatment of medical 2022